AGEN vs ENTX: stock comparison and AI forecast
Agenus Inc (AGEN) and Entera Bio Ltd. (ENTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AGEN Agenus Inc
- Market Cap
- $322M
- P/E Ratio
- 65.0x
- Size
- small-cap
- AI Forecast
ENTX Entera Bio Ltd.
- Price
- $2.99 +118.2% · 6M
- Market Cap
- $518M
- P/E Ratio
- 9.1x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ENTX is 1.6 times larger than AGEN by market capitalization ($518M against $322M).
- ENTX trades at 9.1 times trailing earnings, AGEN at 65.0 times.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AGEN | ENTX |
|---|---|---|
| Market Cap | $322M | $518M |
| P/E Ratio | 65.00x | 9.06x |
| P/B Ratio | – | 71.25x |
| EPS | $0.11 | $0.33 |
| Book Value/Share | – | $0.04 |
| Revenue/Share | $2.98 | $0.00 |
| FCF/Share | $-2.31 | $-0.06 |
Profitability & Margins
| Metric | AGEN | ENTX |
|---|---|---|
| ROIC | 124.6% | -82.9% |
| Gross Margin | 99.7% | – |
| Operating Margin | 38.9% | – |
| EBT Margin | 51.7% | – |
Financial Health
| Metric | AGEN | ENTX |
|---|---|---|
| Current Ratio | 0.73x | 8.98x |
| D/E Ratio | – | 1.68x |
| Financial Leverage | – | 2.68x |
| Interest Coverage | 21.2x | – |
| Working Capital | -$55M | $17M |
Cash Flow
| Metric | AGEN | ENTX |
|---|---|---|
| Operating Cash Flow | -$104M | -$11M |
| Free Cash Flow | -$104M | -$11M |
| Capital Spending | $0.00M | -$70K |
| FCF/Sales | -77.5% | – |
| CapEx/Sales | 0.0% | – |
Operational Efficiency
| Metric | AGEN | ENTX |
|---|---|---|
| Asset Turnover | 0.55x | 0.00x |
| Receivables Turnover | 7.8x | – |
| Fixed Assets Turnover | 9.6x | 0.0x |
| Days Sales Outstanding | 47 days | – |
| Payables Period | 44854 days | – |
Income Statement
| Metric | AGEN | ENTX |
|---|---|---|
| Total Revenue | $134M | $0.00M |
| Operating Income | $52M | -$14M |
| R&D Expense | $46M | $9M |
| SG&A Expense | – | $550K |
| Cost of Goods Sold | $380K | $0.00M |
Dividend & Shareholder Information
| Metric | AGEN | ENTX |
|---|---|---|
| Shares Outstanding | 45M | 173M |
| EPS Growth | – | 32.0% |
AGEN vs ENTX: stock comparison and AI forecast
Which is bigger, AGEN or ENTX?
ENTX is 1.6 times larger than AGEN by market capitalization ($518M against $322M).
Which is cheaper on earnings, AGEN or ENTX?
ENTX trades at 9.1 times trailing earnings, AGEN at 65.0 times.
Which one does Intratio's AI model rank higher, AGEN or ENTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.